Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Dordrecht
Clinical trial register · Netherlands

Clinical Trials in Dordrecht, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3175 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:17 UTC
3175
Studies in scope
all four open statuses
1789
Recruiting now
open to new participants
601
Lead sponsors
across recruiting studies
Top sites
Amsterdam 1243 Rotterdam 855 Groningen 601 Nijmegen 565 Utrecht 545
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Stichting Hemato-Oncologie voor Volwassenen Nederland13 Janssen Research & Development, LLC6 Eli Lilly and Company4 Genmab4 Erasmus Medical Center4 BeOne Medicines4 Merck Sharp & Dohme LLC3 AstraZeneca3 European Myeloma Network B.V.2 Amgen2 Comprehensive Cancer Centre The Netherlands2 Boehringer Ingelheim2 Albert Schweitzer Ziekenhuis, Netherlands2 Novartis Pharmaceuticals2 Pfizer2 Bayer2 Diagram B.V.1 Bristol-Myers Squibb1 Insel Gruppe AG, University Hospital Bern1 Terumo Europe N.V.1 Marieke Duiverman1 Albert Schweitzer Hospital1 GlaxoSmithKline1 Maastricht University Medical Center1 Novo Nordisk A/S1 Show all 62
Site location
Amsterdam1243 Rotterdam855 Groningen601 Nijmegen565 Utrecht545 Maastricht421 Leiden386 Eindhoven209 Arnhem181 Breda173 Nieuwegein151 The Hague121 's-Hertogenbosch120 Tilburg113 Zwolle110 Enschede108 Dordrecht103 Amersfoort96 Leeuwarden87 Alkmaar86 Heerlen65 Delft60 Deventer59 Apeldoorn53 Ede51 Show all 164
All 164 locations
Target enrolment
to

Trials with a site in Dordrecht

103 of 3175 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Not yet open
Novo Nordisk A/S
Phase 3
1,408
Deventer, Dordrecht, Eindhoven, Haarlem, Heerlen, Hoogeveen, Nijmegen, Utrecht
2026-11-11
Not yet open
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
70
Almere Stad, Amersfoort, Amsterdam, Breda, Doetinchem, Dordrecht, Eindhoven, Groningen
2026-09-15
Recruiting
Merck Sharp & Dohme LLC
Phase 2
750
Ede, Harderwijk, Roosendaal, Alkmaar, Sneek, Dordrecht, Groningen
2026-06-30
Recruiting
Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation
NCT07556887Carotid Artery Stenosis Symptomatic, Ischemic Cerebral Infarction, Stroke Ischemic, Atheroscleroses
Maastricht University Medical Center
Not applicable
613
Arnhem, Nijmegen, Heerlen, Maastricht, Amsterdam, Zwolle, Dordrecht, Rotterdam
2026-03-31
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
's-Hertogenbosch, Amersfoort, Amsterdam, Arnhem, Breda, Dordrecht, Eindhoven, Groningen
2026-03-01
Recruiting
BeOne Medicines
Phase 3
500
Almere Stad, Dordrecht, Sgravenhage
2026-01-22
Recruiting
Albert Schweitzer Ziekenhuis, Netherlands
Observational
117
Dordrecht
2025-11-04
Recruiting
Eli Lilly and Company
Phase 3
1,205
Dordrecht, Eindhoven, Nijmegen
2025-10-31
Recruiting
Erasmus Medical Center
Phase 3
103
's-Hertogenbosch, Almelo, Amersfoort, Amsterdam, Breda, Delft, Dordrecht, Eindhoven
2025-10-14
Recruiting
Sanofi
Phase 3
942
Arnhem, Breda, Dordrecht, Nijmegen, The Hague, Zutphen
2025-09-17
Recruiting
BeOne Medicines
Phase 3
500
Dordrecht, EJ Eindhoven, Gouda, Groningen, Nijmegen, Utrecht
2025-09-04
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
's-Hertogenbosch, Amsterdam, Arnhem, Breda, Dordrecht, Eindhoven, Enschede, Geleen
2025-08-05
Active, closed
Novartis Pharmaceuticals
Phase 2
168
Zwolle, Dordrecht, Hoofddorp, Schiedam
2025-07-07
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Amsterdam, Arnhem, Breda, Delft, Deventer, Dordrecht, Eindhoven, Emmen
2025-06-25
Active, closed
AbbVie
Phase 3
573
Nijmegen, Tilburg, Amsterdam, Dordrecht, Rotterdam
2025-06-17
Recruiting
BeOne Medicines
Phase 3
630
Almere Stad, Arnhem, Dordrecht, Hilversum
2025-06-11
Recruiting
Calico Life Sciences LLC
Phase 2
240
Groningen, Dordrecht, Leiden, Rotterdam
2025-06-09
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
's-Hertogenbosch, Amersfoort, Amsterdam, Arnhem, Breda, Delft, Dordrecht, Eindhoven
2025-05-05
Recruiting
Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma
NCT06643286Melanoma (Skin), Melanoma, Stage II, Stage I, Melanoma Stage, Survivorship
Erasmus Medical Center
Not applicable
180
Dordrecht, Rotterdam
2025-04-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Amsterdam, Arnhem, Breda, Dordrecht, Eindhoven, Groningen, Leiden, Maastricht
2025-03-14
Recruiting
AstraZeneca
Phase 3
5,000
Amersfoort, Amsterdam, Dordrecht, Groningen, Hilversum, Leiden, Maastricht, Nieuwegein
2025-03-03
Recruiting
Albert Schweitzer Ziekenhuis, Netherlands
Observational
58
Dordrecht
2025-02-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Dordrecht, Leiden, Amersfoort
2025-01-27
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Dordrecht, Rotterdam, Schiedam
2024-11-12
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Amsterdam, Dordrecht, Nijmegen, Rotterdam, Schiedam, Tilburg
2024-10-14
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Tilburg, Dordrecht, The Hague, Eindhoven
2024-09-27
Recruiting
Janssen Research & Development, LLC
Phase 2
210
Amsterdam, Dordrecht, Rotterdam
2024-08-26
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
324
's-Hertogenbosch, Almelo, Amstelveen, Apeldoorn, Arnhem, Breda, Delft, Dordrecht
2024-08-15
Active, closed
Genmab
Phase 3
379
's-Hertogenbosch, Amsterdam, Leeuwarden, Dordrecht, Nieuwegein
2024-08-13
Recruiting
Spinal Cord Monitoring in Multiple Sclerosis
NCT06827834Multiple Sclerosis
Zuyderland Medisch Centrum
Observational
155
Arnhem, Geleen, 's-Hertogenbosch, Dordrecht, Rotterdam
2024-08-06
Recruiting
Amgen
Phase 3
450
Amsterdam, Dordrecht, Enschede, Groningen, Maastricht, Utrecht
2024-07-17
Recruiting
Erasmus Medical Center
Not applicable
260
Rotterdam, Alkmaar, Breda, Dordrecht, Ede, Eindhoven
2024-04-23
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 1/2
112
's-Hertogenbosch, Alkmaar, Amersfoort, Amsterdam, Dordrecht, Ede, Eindhoven, Groningen
2024-04-15
Active, closed
AstraZeneca
Phase 3
2,554
Alkmaar, Amersfoort, Dordrecht, Hardenberg, Harderwijk, Hilversum, Utrecht
2024-03-29
Recruiting
Italfarmaco
Phase 3
220
Hoofddorp, Enschede, Dordrecht
2024-03-26
Recruiting
Pfizer
Phase 3
492
Maastricht, Dordrecht, Rotterdam
2024-02-08
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
142
's-Hertogenbosch, Amersfoort, Amsterdam, Arnhem, Breda, Dordrecht, Eindhoven, Enschede
2024-01-17
Recruiting
Franciscus Gasthuis
Observational
55,000
Alkmaar, Apeldoorn, Dordrecht, Eindhoven, Emmen, Goes, Heerenveen, Heerlen
2024-01-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Hoofddorp, Dordrecht, Groningen
2023-12-31
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2/3
140
Arnhem, Dordrecht, Hengelo, Utrecht, Zeeland
2023-12-18
Active, closed
BeOne Medicines
Phase 3
652
Alkmaar, Almere Stad, Amersfoort, Amsterdam, Dordrecht, Groningen, Rotterdam, Schiedam
2023-11-11
Active, closed
AstraZeneca
Phase 3
1,835
Amersfoort, Breda, Dordrecht
2023-11-07
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Nijmegen, Dordrecht
2023-09-18
Recruiting
Vitestro B.V.
Not applicable
44,658
Amsterdam, Dordrecht, Nieuwegein, Utrecht
2023-07-21
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Amsterdam, Dordrecht
2023-06-22
Active, closed
Population Health Research Institute
Not applicable
5,100
Amsterdam, Dordrecht, Heerlen, Nijmegen
2023-06-22
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
's-Hertogenbosch, Arnhem, Dordrecht, Eindhoven, Leeuwarden, Rotterdam
2023-04-25
Active, closed
Bayer
Phase 3
985
Hilversum, Dordrecht, Rotterdam, The Hague, Nieuwegein, Groningen
2023-04-03
By invitation
Effectiveness of Personalized Surveillance and Aftercare for Breast Cancer
NCT05975437Breast Cancer, Breast Cancer Female, Survivorship
Comprehensive Cancer Centre The Netherlands
Observational
1,040
Apeldoorn, Arnhem, 's-Hertogenbosch, Uden, Alkmaar, Hengelo, Zwolle, Dordrecht
2023-03-06
Recruiting
High-Risk prostatE Cancer radiatiOn Versus surgERy
NCT05931419Prostate Cancer, Prostate Adenocarcinoma
Comprehensive Cancer Centre The Netherlands
Observational
837
Alkmaar, Amsterdam, Assen, Beverwijk, Dordrecht, Eindhoven, Goes, Groningen
2023-02-16
Recruiting
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
NCT05326620Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic
PROspective Renal Cancer Cohort Foundation
Observational
2,000
Amsterdam, 's-Hertogenbosch, Amersfoort, Apeldoorn, Arnhem, Breda, Deventer, Dordrecht
2023-01-19
Active, closed
MAD Trial: Myopia Atropine Dose
NCT05667454Progressive Myopia
Erasmus Medical Center
Phase 3
550
Almere Stad, Amsterdam, Delft, Deventer, Dordrecht, Ede, Goes, Heerenveen
2022-12-19
Active, closed
Novartis Pharmaceuticals
Phase 3
568
Dordrecht
2022-11-21
Recruiting
Pfizer
Phase 3
1,060
Dordrecht
2022-11-10
Active, closed
Effects of Preoperative Multidisciplinary Team Meetings for High-risk, Adult, Noncardiac Surgical Patients
NCT05703230Interdisciplinary Communication, Postoperative Complications, Noncardiac Surgery, Surgical Procedures, Operative
Rijnstate Hospital
Not applicable
1,200
's-Hertogenbosch, Amersfoort, Amsterdam, Apeldoorn, Dordrecht, Gouda, Groningen, Heerlen
2022-11-01
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Dordrecht, Eindhoven, Rotterdam
2022-10-13
Active, closed
Eli Lilly and Company
Phase 3
15,374
Almelo, Amersfoort, Delft, Dordrecht, Emmen, Groningen, Haarlem, Helmond
2022-10-11
Recruiting
M. Medici
Phase 3
600
Almere Stad, Amsterdam, Apeldoorn, Arnhem, Breda, Dirksland, Dordrecht, Emmen
2022-10-07
Active, closed
Eli Lilly and Company
Phase 3
8,000
Assen, Breda, Delft, Deventer, Dordrecht, Hengelo, Hoofddorp, Maastricht
2022-10-04
Active, closed
Genmab
Phase 3
549
Nijmegen, Breda, Amsterdam, Hoorn, Enschede, Dordrecht, Leiden, Rotterdam
2022-09-20
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Amsterdam, Dordrecht, Maastricht, Rotterdam, Utrecht
2022-09-19
Recruiting
University of Ulm
Phase 3
650
's-Hertogenbosch, Amersfoort, Amsterdam, Arnhem, Breda, Delft, Dordrecht, Eindhoven
2022-09-13
Active, closed
European Myeloma Network B.V.
Phase 3
1,594
Alkmaar, Amsterdam, Dordrecht, Eindhoven, Groningen, Hoorn, Nieuwegein, Rotterdam
2022-09-08
Recruiting
Albert Schweitzer Hospital
Not applicable
248
Dordrecht
2022-09-01
Recruiting
Research Maatschap Cardiologen Rotterdam Zuid
Phase 4
1,656
Breda, Dordrecht, Eindhoven, Nijmegen, Rotterdam, The Hague
2022-07-22
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Amsterdam, Dordrecht, Leiden, Maastricht, Rotterdam, Utrecht
2022-07-22
Active, closed
Celgene
Phase 3
939
Dordrecht, Amsterdam, The Hague
2022-06-23
Recruiting
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
NCT05405270Cervical High Grade Squamous Intraepithelial Lesion, Cervical Intraepithelial Neoplasia Grade 2/3, CIN 2/3, Cervical Intraepithelial Neoplasia
DrugImiquimod
Catharina Ziekenhuis Eindhoven
Observational
410
Breda, Dordrecht, Eindhoven, Hilversum, Leeuwarden, Leiden, Maastricht, Nijmegen
2022-06-01
Recruiting
UNICANCER
Phase 3
300
Dordrecht, Nijmegen
2022-04-19
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Dordrecht, Rotterdam
2022-04-11
Active, closed
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT05333068Multivessel Coronary Artery Disease, Ischemia, Vulnerable Plaque, Coronary Artery Disease
Diagram B.V.
Not applicable
1,223
Amsterdam, Dordrecht, Enschede, Tilburg
2022-03-16
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Doedrecht, Dordrecht, Utrecht, Venlo
2022-03-07
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Amsterdam, Arnhem, Beverwijk, Delft, Dirksland, Dordrecht, Ede, Eindhoven
2022-02-07
Active, closed
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291Coronary Artery Disease, Coronary Artery Stenosis
Fondazione Ricerca e Innovazione Cardiovascolare ETS
Not applicable
1,820
Amsterdam, Dordrecht, Rotterdam, The Hague
2021-11-16
By invitation
Philips Clinical & Medical Affairs Global
Not applicable
3,212
Dordrecht, Enschede, Leeuwarden, Nieuwegein, Nijmegen
2021-06-17
Active, closed
German CLL Study Group
Phase 3
897
's-Hertogenbosch, Alkmaar, Amsterdam, Arnhem, Breda, Delft, Doetinchem, Dordrecht
2021-03-01
Active, closed
Stichting European Myeloma Network
Phase 2
160
Amsterdam, Breda, Dordrecht, Rotterdam
2021-02-22
Active, closed
Amsterdam UMC, location VUmc
Phase 2
60
Alkmaar, Amsterdam, Arnhem, Breda, Dordrecht, Groningen, Nieuwegein, Nijmegen
2021-02-17
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Almelo, Amersfoort, Amsterdam, Arnhem, Breda, Dordrecht, Ede, Eindhoven
2021-01-15
Active, closed
Genmab
Phase 3
483
Arnhem, Breda, Dordrecht, Goes, Roosendaal, Rotterdam
2021-01-13
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
85
Almere Stad, Amersfoort, Amsterdam, Dordrecht, Ede, Eindhoven, Enschede, Gouda
2020-12-29
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
60
's-Hertogenbosch, Amsterdam, Arnhem, Breda, Delft, Dordrecht, Ede, Eindhoven
2020-12-23
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Amsterdam, Dordrecht, Harderwijk, Nijmegen, Rotterdam, The Hague, Utrecht, Zwolle
2020-12-02
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Maastricht, Dordrecht, Utrecht, Amsterdam, Groningen
2020-11-25
Active, closed
Bayer
Phase 3
774
Geleen, Tilburg, Amsterdam, Hilversum, Hoofddorp, Dordrecht, The Hague
2020-10-20
Recruiting
Prospective Bladder Cancer Infrastructure Foundation
Observational
3,600
's-Hertogenbosch, Almelo, Amersfoort, Amsterdam, Arnhem, Breda, Dordrecht, Ede
2020-10-04
Active, closed
European Myeloma Network B.V.
Phase 3
302
Alkmaar, Amersfoort, Amsterdam, Breda, Dordrecht, Geleen, Groningen, Leeuwarden
2020-09-25
Recruiting
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
NCT04263038Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases
DrugRivaroxaban
Drahomir Aujesky
Phase 4
276
Dordrecht, Enschede, Leiden, Rotterdam, The Hague, Zwolle
2020-05-15
Active, closed
GlaxoSmithKline
Phase 3
494
Dordrecht, Groningen
2020-05-07
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
's-Hertogenbosch, Amersfoort, Amsterdam, Arnhem, Breda, Delft, Dordrecht, Eindhoven
2019-12-20
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
140
's-Hertogenbosch, Amersfoort, Amsterdam, Arnhem, Breda, Delft, Doetinchem, Dordrecht
2019-12-05
Recruiting
Copenhagen University Hospital, Rigshospitalet
Phase 2/3
212
Dordrecht, Rotterdam
2019-10-11
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Amsterdam, Dordrecht, Nijmegen
2019-09-26
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Arnhem, Dordrecht, Eindhoven, Rotterdam, Tilburg, Uden
2019-03-21
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
's-Hertogenbosch, Amersfoort, Amsterdam, Arnhem, Breda, Delft, Dordrecht, Eindhoven
2019-03-01
Recruiting
Nasal High-Flow in COPD
NCT03564236COPD Exacerbation
Marieke Duiverman
Not applicable
136
Arnhem, Dordrecht, Groningen
2018-10-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
109
's-Hertogenbosch, Amersfoort, Amsterdam, Apeldoorn, Breda, Delft, Dordrecht, Ede
2018-08-30
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Almere Stad, Amsterdam, Delft, Dordrecht, Eindhoven, Hoofddorp, Sittard-Geleen, Sneek
2018-04-17
Recruiting
Sahajanand Medical Technologies Limited
Observational
10,000
Breda, Eindhoven, Blaricum, Leeuwarden, Dordrecht, Rotterdam, Terneuzen
2018-02-27
Active, closed
Eli Lilly and Company
Phase 3
5,637
Maastricht, Amsterdam, Dordrecht, The Hague
2017-07-12
Active, closed
Acerta Pharma BV
Phase 3
533
Almere Stad, Amsterdam, Blaricum, Breda, Delft, Dordrecht, Geleen, Groningen
2015-07-28
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Amsterdam, Amsterdam-Zuidoost, Blaricum, Dordrecht, Groningen, Heerlen, Nieuwegein, Nijmegen
2014-11-26
Active, closed
The Netherlands Cancer Institute
Phase 2/3
310
Alkmaar, Amsterdam, Delft, Deventer, Dordrecht, Ede, Haarlem, Heerlen
2010-01
Rows per page Showing 1–103 of 103
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-netherlands/city/dordrecht

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,175 studies in total at the last sync on 13 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 103 of those studies with a site in Dordrecht.

How many clinical trials are recruiting in Dordrecht?

50 of the 103 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 49 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Dordrecht), 103 studies
PhaseStudiesRecruitingShare
Phase 3562354.4%
Phase 214513.6%
Observational12911.7%
Not applicable11610.7%
Phase 2/3534.9%
Phase 4332.9%
Phase 1/2211.9%

Most active sponsors

Lead sponsors with the most studies (Dordrecht)
Lead sponsorStudiesRecruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland137
Janssen Research & Development, LLC61
BeOne Medicines43
Eli Lilly and Company41
Erasmus Medical Center43
Genmab40
AstraZeneca31
Merck Sharp & Dohme LLC32
Albert Schweitzer Ziekenhuis, Netherlands22
Amgen22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.